Understanding EMT has significant clinical implications for the diagnosis, prognosis, and treatment of various diseases, particularly cancer. Biomarkers of EMT can be used to identify aggressive tumors and predict patient outcomes. Targeting the molecular pathways involved in EMT offers potential therapeutic opportunities to inhibit tumor progression and metastasis. Additionally, modulating EMT can aid in tissue engineering and regenerative medicine by enhancing cell migration and differentiation.
